Cell and cytokine profile in nasal secretions in cystic fibrosis.
BACKGROUND
Nasal polyposis (NP) frequently complicates the course of cystic fibrosis (CF). The aim of this study was to determine the pattern of inflammatory cells and mediators in nasal secretions from patients with or without NP compared to patients with idiopathic NP and healthy controls.


METHODS
Eighteen CF patients with NP (NP+ group: 6 untreated, 12 treated with nasal steroids), and 15 without NP (NP- group) were included in this prospective study and compared to 9 patients with idiopathic NP and 12 healthy controls. Differential cell count eosinophil cationic protein (ECP), interleukin-5 (IL-5) and IL-8 were determined in nasal lavage fluids.


RESULTS
The total cell count, the number and the percentage of neutrophils and eosinophils, the levels of IL-8, IL-5 and ECP were significantly higher in nasal secretions from both NP+ and NP- as compared with controls. No difference was found between untreated and treated CF patients with NP. No difference was found between NP+ and NP- groups. Compared to idiopathic NP group, both NP+ and NP- groups had higher percentage of neutrophils and lower percentage of eosinophils. There were no differences according to the use of topical steroids, systemic antibiotherapy, or the type of mutation. CF patients with positive nasal culture had a higher percentage of neutrophils than those with negative culture. CF patients with atopy had a higher percentage of eosinophils than non-atopic patients.


CONCLUSIONS
Our results demonstrate that nasal inflammation is a prominent feature in patients with CF and does not differ according to the presence of NP. IL-8 and IL-5 may play crucial roles in recruitment and activation of neutrophils and eosinophils in upper airways of CF patients.
Centre de Soins Mucoviscidose Adulte, Clinique des Maladies Respiratoires, Hôpital A. Calmette, 59037 CHRU Lille Cedex, France.
Cyrille
C
Bergoin
Philippe
P
Gosset
Catherine
C
Lamblin
Florence
F
Bolard
Dominique
D
Turck
André Bernard
AB
Tonnel
Benoît
B
Wallaert
D000293:Adolescent; D015415:Biomarkers / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis / Q000276:immunology; D002452:Cell Count; D003550:Cystic Fibrosis / Q000276:immunology*; D016207:Cytokines / Q000032:analysis / Q000276:immunology*; D047091:Eosinophil Granule Proteins; D004847:Epithelial Cells / Q000276:immunology; D005260:Female; D006801:Humans; D015848:Interleukin-5 / Q000032:analysis / Q000276:immunology; D016209:Interleukin-8 / Q000032:analysis / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D008297:Male; D017817:Nasal Lavage Fluid / Q000276:immunology*; D009297:Nasal Mucosa / Q000166:cytology / Q000276:immunology*; D011446:Prospective Studies; D012260:Ribonucleases / Q000032:analysis / Q000276:immunology
D015415:Biomarkers; D001798:Blood Proteins; D016207:Cytokines; D047091:Eosinophil Granule Proteins; D015848:Interleukin-5; D016209:Interleukin-8; D012260:Ribonucleases